Riboscience LLC
Records under this name other than the patents Riboscience LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 7 of 7 · Back to Riboscience LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,846,810 | Antiviral nucleoside derivatives Term ended Term ended Nov 19, 2023 · From the USPTO record | Term ended | Term ended Nov 19, 2023 | From the USPTO record |
| US 6,784,166 | 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Term ended Term ended Jun 11, 2022 · High confidence | Term ended | Term ended Jun 11, 2022 | High confidence |
| US 8,648,054 | 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Lapsed on the fee record Ended Feb 11, 2022 · Low confidence | Lapsed on the fee record | Ended Feb 11, 2022 | Low confidence |
| US 7,608,599 | Antiviral phosphoramidates Lapsed on the fee record Ended Oct 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2021 | From the USPTO record |
| US 7,608,601 | 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication Lapsed on the fee record Ended Oct 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2021 | From the USPTO record |
| US 9,708,357 | 4'-Azido, 3'-Fluoro Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication Lapsed on the fee record Ended Jul 18, 2021 · High confidence | Lapsed on the fee record | Ended Jul 18, 2021 | High confidence |
| US 9,694,028 | 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication Lapsed on the fee record Ended Jul 4, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 4, 2021 | From the USPTO record |